This inventor holds 1 USPTO granted patent. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David Linder: Innovator in Oligonucleotide Production
Introduction
David Linder is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the preparation of oligonucleotide products. His innovative work has led to the development of a patented process that enhances the quality and efficiency of oligonucleotide production.
Latest Patents
David Linder holds a patent titled "Process for the preparation of spray dried oligonucleotide products with controlled humidity." This patent represents a crucial advancement in the production of oligonucleotides, which are essential components in various biotechnological applications. He has 1 patent to his name, showcasing his expertise and commitment to innovation in this specialized field.
Career Highlights
Linder is currently employed at F. Hoffmann-La Roche AG, a leading global healthcare company. His role at Roche allows him to work at the forefront of pharmaceutical and biotechnology advancements. His contributions have been instrumental in enhancing the company's capabilities in oligonucleotide production.
Collaborations
David Linder collaborates with Martin Olbrich, a fellow innovator in the field. Together, they work on projects that aim to push the boundaries of biotechnology and improve the efficiency of oligonucleotide production processes.
Conclusion
David Linder's work exemplifies the spirit of innovation in biotechnology. His patented process for oligonucleotide production is a testament to his dedication to advancing the field. Through his career at F. Hoffmann-La Roche AG, he continues to make impactful contributions that benefit the scientific community and the healthcare industry.